HAP Trading’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-152
Closed -$1K 1223
2022
Q4
$1K Sell
152
-21
-12% -$26.4K ﹤0.01% 1395
2022
Q3
$5K Sell
173
-9
-5% -$11.9K ﹤0.01% 1433
2022
Q2
$8K Buy
182
+32
+21% +$32.9K ﹤0.01% 1519
2022
Q1
$16K Buy
150
+62
+70% +$83.7K ﹤0.01% 1648
2021
Q4
$14K Buy
88
+1
+1% +$2.67K ﹤0.01% 1942
2021
Q3
$12K Sell
87
-12
-12% -$42K ﹤0.01% 1950
2021
Q2
$54K Buy
99
+18
+22% +$71.1K ﹤0.01% 1456
2021
Q1
$32K Buy
+81
New +$457K ﹤0.01% 1300

Other funds holding BNGO

HAP Trading's BNGO Position: Q3 2021 in Review

HAP Trading sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 77 shares — an estimated $269K sold.

HAP Trading first reported a position in BNGO in Q1 2021 and held it in 2 quarters. The position peaked at $486K in Q1 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

  • HAP Trading reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
  • HAP Trading sold 77 Bionano Genomics shares in Q3 2021, an estimated $269K.
  • HAP Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 2 quarters.
  • HAP Trading's Bionano Genomics position peaked at $486K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.